An in vitro model of morphine withdrawal manifests the enhancing effect on human immunodeficiency virus infection of human T lymphocytes through the induction of substance P.
Xu Wang, Steven D Douglas, Jin-Song Peng, Dun-Jin Zhou, Qi Wan, Wen-Zhe Ho
Index: Am. J. Pathol. 169(5) , 1663-70, (2006)
Full Text: HTML
Abstract
Opioid withdrawal is a crucial and recurring event during the course of opioid abuse that has a negative impact on the immune system. In this study, we investigated whether abrupt withdrawal (AW) or precipitated withdrawal (PW) potentiates human immunodeficiency virus (HIV) infection of human T lymphocytes. AW and PW enhanced HIV infection of peripheral blood lymphocytes and T-cell lines (Jurkat and CEMX174). In addition, both AW and PW induced HIV replication in a latently HIV-infected human T-cell line (J1.1). The enhancing effect of AW and PW was associated with the induction of neuropeptide substance P in both peripheral blood lymphocytes and the T-cell lines. The substance P receptor antagonist, CP-96,345, not only blocked AW- or PW-induced endogenous substance P expression but also abrogated AW- or PW-induced HIV replication in T cells. These findings provide a cellular mechanism that supports the notion that opioids have a co-factor role in promoting HIV infection of the immune cells.
Related Compounds
Related Articles:
2015-02-01
[Br. J. Pharmacol. 172(3) , 924-39, (2015)]
2008-05-01
[Am. J. Physiol. Lung Cell. Mol. Physiol. 294(5) , L912-20, (2008)]
2006-10-01
[J. Neuroimmunol. 179(1-2) , 1-8, (2006)]
2008-10-10
[Neurosci. Lett. 443(3) , 257-60, (2008)]
2015-11-01
[Pharmacol. Biochem. Behav. 79(1) , 125-35, (2004)]